Budd-Chiari Syndrome is a rare condition characterized by the obstruction or narrowing of the hepatic veins, which carry blood from the liver back to the heart. This obstruction can occur at various levels, leading to impaired blood flow and potential liver damage.
The syndrome can be caused by a variety of factors, including blood clotting disorders, liver diseases, and certain cancers. Symptoms may vary depending on the severity and location of the blockage, but commonly include abdominal pain, ascites (fluid accumulation in the abdomen), hepatomegaly (enlarged liver), and jaundice.
Diagnosis of Budd-Chiari Syndrome involves a combination of medical history evaluation, physical examination, imaging tests (such as ultrasound, CT scan, or MRI), and blood tests to assess liver function and identify potential underlying causes.
Treatment options depend on the cause and severity of the syndrome. They may include medication to dissolve blood clots, procedures to relieve the obstruction (such as angioplasty or stent placement), or in severe cases, liver transplantation.
Early detection and prompt management are crucial in improving outcomes for individuals with Budd-Chiari Syndrome.